Recombinant human semenogelin-1 (Sg1) and Sg1 (1-159) form detergent stable amyloid like aggregates in vitro

Protein and Peptide Letters

Volumn 23, Issue 1, 2016, Pages 87-96

  Sharma, Neetu ^a   Vishwanath, S ^a   Patel, Basant K ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY HYDERABAD   (India)

Author keywords

Amyloid aggregation; Sarkosyl stability; Semenogelin 1; Senile seminal vesicle amyloidosis; Zinc

Indexed keywords

CONGO RED; RECOMBINANT HUMAN SEMENOGELIN 1; RECOMBINANT HUMAN SEMENOGELIN 1 (1-159); RECOMBINANT PROTEIN; THIOFLAVINE; UNCLASSIFIED DRUG; ZINC ION; AMYLOID; DETERGENT; PEPTIDE FRAGMENT; PROTEIN AGGREGATE; SEMINAL VESICLE SECRETORY PROTEIN; SEMINAL VESICLE-SPECIFIC ANTIGEN; ZINC;

AMINO ACID SEQUENCE; AMYLOIDOGENICITY; AMYLOIDOSIS; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DETERGENT STABILITY; DISEASE ASSOCIATION; GENERAL ASPECTS OF DISEASE; IN VITRO STUDY; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR WEIGHT; PATHOGENESIS; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; SEMINAL VESICLE DISEASE; SENILE SEMINAL VESICLE AMYLOIDOSIS; ULTRAVIOLET SPECTROSCOPY; CHEMISTRY; DRUG EFFECTS; GENETICS; HUMAN; MALE; METABOLISM; SEMINAL VESICLE;

AMYLOID; DETERGENTS; HUMANS; IN VITRO TECHNIQUES; MALE; PEPTIDE FRAGMENTS; PROTEIN AGGREGATES; RECOMBINANT PROTEINS; SEMINAL VESICLE SECRETORY PROTEINS; SEMINAL VESICLES; ZINC;

EID: 84953729964     PISSN: 09298665     EISSN: 18755305     Source Type: Journal    
DOI: 10.2174/0929866523666151106122746     Document Type: Article

References (55)

1. Dobson, C. M. Protein folding and misfolding. Nature, 2003, 426, 884-890.
2. Sarkar, N.; Dubey, V. K. Exploring critical determinants of protein amyloidogenesis: a review. J. Peptide Sci., 2013, 19, 529-536.
3. Eichner, T.; Radford, S. E. A diversity of assembly mechanisms of a generic amyloid fold. Mol. Cell, 2011, 43, 8-18.
4. Cherny, I.; Gazit, E. Amyloids: not only pathological agents but also ordered nanomaterials. Angew. Chem. Int. Ed. Engl., 2008, 47, 4062-4069.
5. LeVine, H., 3rd Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci., 1993, 2, 404-410.
6. Argon, A.; Simsir, A.; Sarsik, B.; Tuna, B.; Yorukoglu, K.; Niflioglu, G. G.; Sen, S. Amyloidosis of seminal vesicles; incidence and pathologic characteristics. Turk Patoloji Derg, 2012, 28, 44-48.
7. Herranz Fernandez, L. M.; Arellano Ganan, R.; Nam Cha, S.; Jimenez Galvez, M.; Pereira Sanz, I. [Localized amyloidosis of the seminal vesicles]. Actas Urol. Esp., 2003, 27, 825-828.
8. Pitkanen, P.; Westermark, P.; Cornwell, G. G., 3rd; Murdoch, W. Amyloid of the seminal vesicles. A distinctive and common localized form of senile amyloidosis. Am. J. Pathol., 1983, 110, 64-69.
9. Elzanaty, S. Association between age and epididymal and accessory sex gland function and their relation to sperm motility. Arch. Androl., 2007, 53, 149-156.
10. Molina, R. I.; Martini, A. C.; Tissera, A.; Olmedo, J.; Senestrari, D.; de Cuneo, M. F.; Ruiz, R. D. Semen quality and aging: analysis of 9.168 samples in Cordoba. Argentina. Arch. Esp. Urol., 2010, 63, 214-222.
11. Yoshida, K.; Kawano, N.; Yoshiike, M.; Yoshida, M.; Iwamoto, T.; Morisawa, M. Physiological roles of semenogelin I and zinc in sperm motility and semen coagulation on ejaculation in humans. Mol. Hum. Reprod., 2008, 14, 151-156.
12. Linke, R. P.; Joswig, R.; Murphy, C. L.; Wang, S.; Zhou, H.; Gross, U.; Rocken, C.; Westermark, P.; Weiss, D. T.; Solomon, A. Senile seminal vesicle amyloid is derived from semenogelin I. J. Lab. Clin. Med., 2005, 145, 187-193.
13. Sipe, J. D.; Benson, M. D.; Buxbaum, J. N.; Ikeda, S.; Merlini, G.; Saraiva, M. J.; Westermark, P. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid, 2010, 17, 101-104.
14. Lilja, H.; Abrahamsson, P. A.; Lundwall, A. Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa. J. Biol. Chem., 1989, 264, 1894-1900.
15. Robert, M.; Gibbs, B. F.; Jacobson, E.; Gagnon, C. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I. Biochemistry, 1997, 36, 3811-3819.
16. Zhang, S.; Fang, J.; Zhang, X.; Qin, C.; Su, S.; Deng, Y.; Song, Z.; Zhang, Y.; Wang, H.; Yin, C.; Wang, Z. Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis. Tumour Biol., 2014, 35(9), 9095-100.
17. Rodrigues, R. G.; Panizo-Santos, A.; Cashel, J. A.; Krutzsch, H. C.; Merino, M. J.; Roberts, D. D. Semenogelins are ectopically expressed in small cell lung carcinoma. Clin. Cancer Res., 2001, 7, 854-860.
18. Zhang, Y.; Wang, Z.; Liu, H.; Giles, F. J.; Lim, S. H. Pattern of gene expression and immune responses to Semenogelin 1 in chronic hematologic malignancies. J. Immunother., 2003, 26, 461-467.
19. Lim, S. H.; Zhang, Y.; Zhang, J. Cancer-testis antigens: the current status on antigen regulation and potential clinical use. Am. J. Blood Res., 2012, 2, 29-35.
20. Robert, M.; Gagnon, C. Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin. Biol. Reprod., 1996, 55, 813-821.
21. Patel, B. K.; Gavin-Smyth, J.; Liebman, S. W. The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion. Nat. Cell Biol., 2009, 11, 344-349.
22. Roan, N. R.; Muller, J. A.; Liu, H.; Chu, S.; Arnold, F.; Sturzel, C. M.; Walther, P.; Dong, M.; Witkowska, H. E.; Kirchhoff, F.; Munch, J.; Greene, W. C. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe, 2011, 10, 541-550.
23. French, K. C.; Roan, N. R.; Makhatadze, G. I. Structural characterization of semen coagulum-derived SEM1 (86-107) amyloid fibrils that enhance HIV-1 infection. Biochemistry, 2014, 53, 3267-3277.
24. Roan, N. R.; Chu, S.; Liu, H.; Neidleman, J.; Witkowska, H. E.; Greene, W. C. Interaction of fibronectin with semen amyloids synergistically enhances HIV infection. J. Infect. Dis., 2014, 210, 1062-1066.
25. Frohm, B.; DeNizio, J. E.; Lee, D. S.; Gentile, L.; Olsson, U.; Malm, J.; Akerfeldt, K. S.; Linse, S. A peptide from human semenogelin I self-assembles into a pH-responsive hydrogel. Soft Matter, 2015, 11, 414-421.
26. House, E.; Mold, M.; Collingwood, J.; Baldwin, A.; Goodwin, S.; Exley, C. Copper abolishes the beta-sheet secondary structure of preformed amyloid fibrils of amyloid-beta (42). J. Alzheimers Dis., 2009, 18, 811-817.
27. Tougu, V.; Karafin, A.; Zovo, K.; Chung, R. S.; Howells, C.; West, A. K.; Palumaa, P. Zn (II) - and Cu (II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators. J. Neurochem., 2009, 110, 1784-1795.
28. Sambrook, J.; Russell, D., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, 2001.
29. Patel, B. K.; Liebman, S. W. "Prion-proof" for [PIN+]: infection with in vitro-made amyloid aggregates of Rnq1p-(132-405) induces [PIN+]. J. Mol. Biol., 2007, 365, 773-782.
30. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970, 227, 680-685.
31. Aitken, A.; Learmonth, M. Protein Determination by UV Absorption, in: J. Walker (Ed.) The Protein Protocols Handbook, Humana Press, 1996, pp. 3-6.
32. Wilkins, M. R.; Gasteiger, E.; Bairoch, A.; Sanchez, J. C.; Williams, K. L.; Appel, R. D.; Hochstrasser, D. F. Protein identification and analysis tools in the ExPASy server. Methods Mol. Biol., 1999, 112, 531-552.
33. Dickinson, J.; Fowler, S. Quantification of Proteins on Western Blots Using ECL, in: J. Walker (Ed.) The Protein Protocols Handbook, Humana Press, 2002, pp. 429-437.
34. Serio, T. R.; Cashikar, A. G.; Kowal, A. S.; Sawicki, G. J.; Moslehi, J. J.; Serpell, L.; Arnsdorf, M. F.; Lindquist, S. L. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science, 2000, 289, 1317-1321.
35. Wiesbauer, J.; Prassl, R.; Nidetzky, B. Renewal of the air-water interface as a critical system parameter of protein stability: aggregation of the human growth hormone and its prevention by surfaceactive compounds. Langmuir, 2013, 29, 15240-15250.
36. DePace, A. H.; Santoso, A.; Hillner, P.; Weissman, J. S. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell, 1998, 93, 1241-1252.
37. Klunk, W. E.; Jacob, R. F.; Mason, R. P. Quantifying amyloid betapeptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay. Anal. Biochem., 1999, 266, 66-76.
38. Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science, 1982, 216, 136-144.
39. Taneja, V.; Maddelein, M. L.; Talarek, N.; Saupe, S. J.; Liebman, S. W. A non-Q/N-rich prion domain of a foreign prion, [Het-s], can propagate as a prion in yeast. Mol. Cell, 2007, 27, 67-77.
40. Bagriantsev, S. N.; Kushnirov, V. V.; Liebman, S. W. Analysis of amyloid aggregates using agarose gel electrophoresis. Methods Enzymol., 2006, 412, 33-48.
41. Schagger, H. Tricine-SDS-PAGE. Nat. Protoc., 2006, 1, 16-22.
42. Norlin, N.; Hellberg, M.; Filippov, A.; Sousa, A. A.; Grobner, G.; Leapman, R. D.; Almqvist, N.; Antzutkin, O. N. Aggregation and fibril morphology of the Arctic mutation of Alzheimer's Abeta peptide by CD, TEM, STEM and in situ AFM. J. Struct. Biol., 2012, 180, 174-189.
43. De Felice, F. G.; Vieira, M. N.; Saraiva, L. M.; Figueroa-Villar, J. D.; Garcia-Abreu, J.; Liu, R.; Chang, L.; Klein, W. L.; Ferreira, S. T. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. FASEB J., 2004, 18, 1366-1372.
44. Vieira, M. N.; Figueroa-Villar, J. D.; Meirelles, M. N.; Ferreira, S. T.; De Felice, F. G. Small molecule inhibitors of lysozyme amyloid aggregation. Cell Biochem. Biophys., 2006, 44, 549-553.
45. Malm, J.; Hellman, J.; Magnusson, H.; Laurell, C. B.; Lilja, H. Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II. Eur. J. Biochem., 1996, 238, 48-53.
46. Robert, M.; Gagnon, C. Semenogelin I: a coagulum forming, multifunctional seminal vesicle protein. CMLS, 1999, 55, 944-960.
47. Malm, J.; Jonsson, M.; Frohm, B.; Linse, S. Structural properties of semenogelin I. FEBS J., 2007, 274, 4503-4510.
48. Owen, D. H.; Katz, D. F. A review of the physical and chemical properties of human semen and the formulation of a semen simulant. J. Androl., 2005, 26, 459-469.
49. Harnisch, B.; Oates, R., Pre-IVF Evaluation of the Infertile Man, in: E. S. Ginsburg, C. Racowsky (Eds.) In Vitro Fertilization, Springer New York, 2012, pp. 17-29.
50. Borysik, A. J.; Morten, I. J.; Radford, S. E.; Hewitt, E. W. Specific glycosaminoglycans promote unseeded amyloid formation from beta2-microglobulin under physiological conditions. Kidney Intl., 2007, 72, 174-181.
51. Bagriantsev, S.; Liebman, S. W. Specificity of prion assembly in vivo. [PSI+] and [PIN+] form separate structures in yeast. J. Biol. Chem., 2004, 279, 51042-51048.
52. Collins, S. R.; Douglass, A.; Vale, R. D.; Weissman, J. S. Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol., 2004, 2, e321.
53. Vitrenko, Y. A.; Gracheva, E. O.; Richmond, J. E.; Liebman, S. W. Visualization of aggregation of the Rnq1 prion domain and crossseeding interactions with Sup35NM. J. Biol. Chem., 2007, 282, 1779-1787.
54. Jonsson, M.; Linse, S.; Frohm, B.; Lundwall, A.; Malm, J. Semenogelins I and II bind zinc and regulate the activity of prostatespecific antigen. Biochem. J., 2005, 387, 447-453.
55. Sarkar, M.; Kumar M.; Dubey, VK. Exploring possibility of promiscuity of amyloid inhibitor: Studies on effect of selected compounds on folding and amyloid formation of proteins. Proc. Biochem., 2011, 46, 1179-1185.